GB201511478D0 - Blended formulations - Google Patents

Blended formulations

Info

Publication number: GB201511478D0
Authority: GB; United Kingdom
Prior art keywords: blended formulations; blended; formulations
Prior art date: 2015-06-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1511478.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sequessome Technology Holdings Ltd

Original Assignee

Sequessome Technology Holdings Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-06-30

Filing date

2015-06-30

Publication date

2015-08-12

2015-06-30 Application filed by Sequessome Technology Holdings Ltd filed Critical Sequessome Technology Holdings Ltd

2015-06-30 Priority to GBGB1511478.8A priority Critical patent/GB201511478D0/en

2015-08-12 Publication of GB201511478D0 publication Critical patent/GB201511478D0/en

2016-06-30 Priority to EP16733595.9A priority patent/EP3316857B1/en

2016-06-30 Priority to PT167335959T priority patent/PT3316857T/en

2016-06-30 Priority to DK16733592.6T priority patent/DK3316856T3/en

2016-06-30 Priority to EP21189470.4A priority patent/EP3954361A1/en

2016-06-30 Priority to MX2018000021A priority patent/MX382034B/en

2016-06-30 Priority to HK18114088.4A priority patent/HK1254979B/en

2016-06-30 Priority to PT167335926T priority patent/PT3316856T/en

2016-06-30 Priority to JP2017568160A priority patent/JP6851998B2/en

2016-06-30 Priority to US15/739,575 priority patent/US10744090B2/en

2016-06-30 Priority to HRP20211669TT priority patent/HRP20211669T1/en

2016-06-30 Priority to HUE16733595A priority patent/HUE056161T2/en

2016-06-30 Priority to ES16733595T priority patent/ES2895910T3/en

2016-06-30 Priority to PCT/EP2016/065425 priority patent/WO2017001625A1/en

2016-06-30 Priority to US15/739,570 priority patent/US20190167588A1/en

2016-06-30 Priority to HRP20210903TT priority patent/HRP20210903T1/en

2016-06-30 Priority to MX2018000024A priority patent/MX381075B/en

2016-06-30 Priority to PCT/EP2016/065415 priority patent/WO2017001617A1/en

2016-06-30 Priority to ES16733592T priority patent/ES2879383T3/en

2016-06-30 Priority to LTEP16733592.6T priority patent/LT3316856T/en

2016-06-30 Priority to HK18114089.3A priority patent/HK1254980B/en

2016-06-30 Priority to EA201890119A priority patent/EA038613B1/en

2016-06-30 Priority to CA3026484A priority patent/CA3026484A1/en

2016-06-30 Priority to EA202191091A priority patent/EA202191091A3/en

2016-06-30 Priority to CA3026466A priority patent/CA3026466A1/en

2016-06-30 Priority to PL16733595T priority patent/PL3316857T3/en

2016-06-30 Priority to HUE16733592A priority patent/HUE054749T2/en

2016-06-30 Priority to EA201890120A priority patent/EA038208B1/en

2016-06-30 Priority to LTEPPCT/EP2016/065425T priority patent/LT3316857T/en

2016-06-30 Priority to MX2021004766A priority patent/MX2021004766A/en

2016-06-30 Priority to DK16733595.9T priority patent/DK3316857T3/en

2016-06-30 Priority to PL16733592T priority patent/PL3316856T3/en

2016-06-30 Priority to EP16733592.6A priority patent/EP3316856B1/en

2017-12-20 Priority to MX2021003510A priority patent/MX2021003510A/en

2020-07-08 Priority to US16/923,810 priority patent/US20220370353A9/en

2020-07-14 Priority to US16/929,009 priority patent/US11547665B2/en

2021-03-10 Priority to JP2021038221A priority patent/JP2021091730A/en

2023-10-19 Priority to US18/490,255 priority patent/US20240099976A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Birds (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

GBGB1511478.8A 2015-06-30 2015-06-30 Blended formulations Ceased GB201511478D0 (en)

Priority Applications (38)

Application Number	Priority Date	Filing Date	Title
GBGB1511478.8A GB201511478D0 (en)	2015-06-30	2015-06-30	Blended formulations
EP16733592.6A EP3316856B1 (en)	2015-06-30	2016-06-30	Blended formulations
ES16733592T ES2879383T3 (en)	2015-06-30	2016-06-30	Mixed formulas
LTEP16733592.6T LT3316856T (en)	2015-06-30	2016-06-30	MIXED COMPOSITIONS
DK16733592.6T DK3316856T3 (en)	2015-06-30	2016-06-30	MIXED FORMULATIONS
EP21189470.4A EP3954361A1 (en)	2015-06-30	2016-06-30	Multiphasic compositions
MX2018000021A MX382034B (en)	2015-06-30	2016-06-30	MULTIPHASE COMPOSITIONS.
HK18114088.4A HK1254979B (en)	2015-06-30	2016-06-30	Multiphasic compositions
PT167335926T PT3316856T (en)	2015-06-30	2016-06-30	Blended formulations
JP2017568160A JP6851998B2 (en)	2015-06-30	2016-06-30	Polyphase composition
US15/739,575 US10744090B2 (en)	2015-06-30	2016-06-30	Multiphasic compositions
EA201890119A EA038613B1 (en)	2015-06-30	2016-06-30	Blended formulations
HUE16733595A HUE056161T2 (en)	2015-06-30	2016-06-30	Multiphase preparations
ES16733595T ES2895910T3 (en)	2015-06-30	2016-06-30	Multiphase compositions
PCT/EP2016/065425 WO2017001625A1 (en)	2015-06-30	2016-06-30	Multiphasic compositions
US15/739,570 US20190167588A1 (en)	2015-06-30	2016-06-30	Blended formulations
HRP20210903TT HRP20210903T1 (en)	2015-06-30	2016-06-30	Blended formulations
MX2018000024A MX381075B (en)	2015-06-30	2016-06-30	MIXED FORMULATIONS.
PCT/EP2016/065415 WO2017001617A1 (en)	2015-06-30	2016-06-30	Blended formulations
EP16733595.9A EP3316857B1 (en)	2015-06-30	2016-06-30	Multiphasic compositions
HK18114089.3A HK1254980B (en)	2015-06-30	2016-06-30	Blended formulations
PT167335959T PT3316857T (en)	2015-06-30	2016-06-30	Multiphasic compositions
HRP20211669TT HRP20211669T1 (en)	2015-06-30	2016-06-30	Multiphasic compositions
CA3026484A CA3026484A1 (en)	2015-06-30	2016-06-30	Multiphasic compositions comprising a collodial dispersion and uses thereof
EA202191091A EA202191091A3 (en)	2015-06-30	2016-06-30	MULTI-PHASE COMPOSITIONS
CA3026466A CA3026466A1 (en)	2015-06-30	2016-06-30	Blended formulations
PL16733595T PL3316857T3 (en)	2015-06-30	2016-06-30	Multiphasic compositions
HUE16733592A HUE054749T2 (en)	2015-06-30	2016-06-30	Mixed preparations
EA201890120A EA038208B1 (en)	2015-06-30	2016-06-30	Multiphasic compositions
LTEPPCT/EP2016/065425T LT3316857T (en)	2015-06-30	2016-06-30	MULTI - PHASE COMPOSITIONS
MX2021004766A MX2021004766A (en)	2015-06-30	2016-06-30	Multiphasic compositions.
DK16733595.9T DK3316857T3 (en)	2015-06-30	2016-06-30	MULTIFASIC COMPOSITIONS
PL16733592T PL3316856T3 (en)	2015-06-30	2016-06-30	Blended formulations
MX2021003510A MX2021003510A (en)	2015-06-30	2017-12-20	Blended formulations.
US16/923,810 US20220370353A9 (en)	2015-06-30	2020-07-08	Blended formulations
US16/929,009 US11547665B2 (en)	2015-06-30	2020-07-14	Multiphasic compositions
JP2021038221A JP2021091730A (en)	2015-06-30	2021-03-10	Multiphasic compositions
US18/490,255 US20240099976A1 (en)	2015-06-30	2023-10-19	Blended formulations

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1511478.8A GB201511478D0 (en)	2015-06-30	2015-06-30	Blended formulations

Publications (1)

Publication Number	Publication Date
GB201511478D0 true GB201511478D0 (en)	2015-08-12

Family

ID=53872458

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1511478.8A Ceased GB201511478D0 (en)	2015-06-30	2015-06-30	Blended formulations

Country Status (2)

Country	Link
EA (1)	EA202191091A3 (en)
GB (1)	GB201511478D0 (en)

2015
- 2015-06-30 GB GBGB1511478.8A patent/GB201511478D0/en not_active Ceased
2016
- 2016-06-30 EA EA202191091A patent/EA202191091A3/en unknown

Also Published As

Publication number	Publication date
EA202191091A2 (en)	2021-12-31
EA202191091A3 (en)	2022-02-28

Publication	Publication Date	Title
IL273541A (en)	2020-05-31	Formulations
IL273282A (en)	2020-04-30	Niraparib formulations
IL269630A (en)	2019-11-28	Niraparib formulations
IL257279A (en)	2018-03-29	Stable anti-ifnar1 formulation
IL269621A (en)	2019-11-28	Niraparib formulations
IL265609A (en)	2019-05-30	Novel formulations
GB201607918D0 (en)	2016-06-22	Novel formulations
GB201419091D0 (en)	2014-12-10	Formulations
GB201419261D0 (en)	2014-12-10	Formulations
GB201514758D0 (en)	2015-09-30	Formulation
PT3316856T (en)	2021-07-06	Blended formulations
PT3173071T (en)	2021-04-15	Maropitant formulation
GB201521771D0 (en)	2016-01-27	Formulation
GB201511255D0 (en)	2015-08-12	Formulation
GB201509891D0 (en)	2015-07-22	Formulation
GB201511478D0 (en)	2015-08-12	Blended formulations
GB201621277D0 (en)	2017-01-25	Formulations
GB201714461D0 (en)	2017-10-25	Formulations
GB201618110D0 (en)	2016-12-07	Formulations
GB201616366D0 (en)	2016-11-09	Formulations
GB201615754D0 (en)	2016-11-02	Formulations
GB201507784D0 (en)	2015-06-17	Formulations
GB201505532D0 (en)	2015-05-13	Formulations
GB201617866D0 (en)	2016-12-07	Novel formulations
GB201616509D0 (en)	2016-11-16	Novel formulations

Legal Events

Date	Code	Title	Description
2017-03-01	AT	Applications terminated before publication under section 16(1)
2017-07-26	S30Z	Assignments for licence or security reasons	Free format text: APPLICANT. SEQUESSOME TECHNOLOGY HOLDIGS LIMITED SECURITY INTEREST. FONDS RUSNANO CAPITAL S.A.